Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chlorzoxazone measurement (procedure) |
Has measured component (attribute) |
False |
Chlorzoxazone |
Inferred relationship |
Some |
|
Chlorzoxazone measurement (procedure) |
Component |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorzoxazone |
Inferred relationship |
Some |
|
Chlorzoxazone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorzoxazone |
Inferred relationship |
Some |
|
Chlorzoxazone 375 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorzoxazone |
Inferred relationship |
Some |
|
Chlorzoxazone 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorzoxazone |
Inferred relationship |
Some |
|
Chlorzoxazone 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 375 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 375 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 750 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 375 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 750 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Product containing chlorzoxazone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Product containing only chlorzoxazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Chlorzoxazone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
1 |
Aceclofenac 100 mg and chlorzoxazone 250 mg and paracetamol 325 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorzoxazone |
Inferred relationship |
Some |
3 |
Aceclofenac 100 mg and chlorzoxazone 250 mg and paracetamol 325 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
3 |
Product containing aceclofenac and chlorzoxazone and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
3 |
Aceclofenac- and chlorzoxazone- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
3 |
Aceclofenac and chlorzoxazone and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
3 |
Product containing only aceclofenac and chlorzoxazone and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
3 |
Chlorzoxazone and diclofenac and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
2 |
Product containing chlorzoxazone and diclofenac and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
2 |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorzoxazone |
Inferred relationship |
Some |
2 |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
2 |
Chlorzoxazone- and diclofenac- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
2 |
Chlorzoxazone and diclofenac and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
2 |
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorzoxazone |
Inferred relationship |
Some |
2 |
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
2 |
Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorzoxazone |
Inferred relationship |
Some |
3 |
Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorzoxazone |
Inferred relationship |
Some |
3 |